Seres Therapeutics, Inc. — Form 10-Q
Filed November 4, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
Marella Thorell resigned from employment effective November 15, 2026. Seres retained her as non-employee advisor at $500/hour for up to 20 hours/month through March 31, 2027 (maximum ~$30K). Her equity awards continue vesting during the advisory period, and stock options' post-termination exercise period is delayed until after advisory ends. She remains bound by existing non-compete and confidentiality agreements.
Why this rating
Routine executive departure with standard post-termination advisory arrangement. ~$30K advisory cost is immaterial to $71.9M market cap. No strategic shift or major financial impact disclosed.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.